Baselight is shutting down June 30.
Export any data that you want to keep. Read the announcement.
Datasets
Total public datasets added
38,678
Rows
Total rows contributed
18,722,780,907
Popularity
Total times datasets used in queries
11
Stars
Total stars received
2
Datasets
Explore the CatalogDataset
Last Changed
Tables
Size
Stars
Product Data For Newly Reported Drugs In The Medicaid Drug Rebate Program 2023-02-13-to-2023-02-19
U.S. Department of Health & Human Services
Finance and EconomicsProduct Data For Newly Reported Drugs In The Medicaid Drug Rebate Program 2023-11-20-to-2023-11-26
U.S. Department of Health & Human Services
Finance and EconomicsProduct Data For Newly Reported Drugs In The Medicaid Drug Rebate Program 03-25-2024-to-03-31-2024
U.S. Department of Health & Human Services
Finance and EconomicsProduct Data For Newly Reported Drugs In The Medicaid Drug Rebate Program 2023-12-25-to-2023-12-31
U.S. Department of Health & Human Services
Finance and EconomicsNNDSS - TABLE 1OO. Viral Hemorrhagic Fevers, Machupo Virus To Viral Hemorrhagic Fevers, Sabia Virus
U.S. Department of Health & Human Services
Demographics and Population StudiesProduct Data For Newly Reported Drugs In The Medicaid Drug Rebate Program 20211011 To 20211017
U.S. Department of Health & Human Services
Finance and EconomicsProduct Data For Newly Reported Drugs In The Medicaid Drug Rebate Program 2022-01-31 To 2022-02-06
U.S. Department of Health & Human Services
Finance and EconomicsProduct Data For Newly Reported Drugs In The Medicaid Drug Rebate Program 02-26-2024-to-03-03-2024
U.S. Department of Health & Human Services
Finance and EconomicsNNDSS - Table 1B. Arboviral Diseases, Jamestown Canyon Virus Disease To Powassan Virus Disease
U.S. Department of Health & Human Services
HealthcareNNDSS - TABLE 1O. Hansen's Disease To Hantavirus Pulmonary Syndrome
U.S. Department of Health & Human Services
HealthcareProduct Data For Newly Reported Drugs In The Medicaid Drug Rebate Program 2023-06-26-to-2023-07-02
U.S. Department of Health & Human Services
Finance and EconomicsNNDSS - TABLE 1LL. Vibriosis, Confirmed To Vibriosis, Probable
U.S. Department of Health & Human Services
Demographics and Population StudiesNNDSS - TABLE 1LL. Vibriosis, Confirmed To Vibriosis, Probable
U.S. Department of Health & Human Services
Demographics and Population StudiesProduct Data For Newly Reported Drugs In The Medicaid Drug Rebate Program 20211004 To 20211010
U.S. Department of Health & Human Services
Finance and EconomicsProduct Data For Newly Reported Drugs In The Medicaid Drug Rebate Program 2022-02-14 To 2022-02-20
U.S. Department of Health & Human Services
Finance and EconomicsNNDSS - TABLE 1OO. Viral Hemorrhagic Fevers, Machupo Virus To Viral Hemorrhagic Fevers, Sabia Virus
U.S. Department of Health & Human Services
Demographics and Population StudiesProduct Data For Newly Reported Drugs In The Medicaid Drug Rebate Program 2023-03-20-to-2023-03-26
U.S. Department of Health & Human Services
Finance and EconomicsProduct Data For Newly Reported Drugs In The Medicaid Drug Rebate Program 2023-10-02-to-2023-10-08
U.S. Department of Health & Human Services
Finance and EconomicsNNDSS - TABLE 1BB. Q Fever, Total To Q Fever, Chronic
U.S. Department of Health & Human Services
Demographics and Population StudiesNNDSS - TABLE 1I. Cryptosporidiosis To Cyclosporiasis
U.S. Department of Health & Human Services
Demographics and Population StudiesProduct Data For Newly Reported Drugs In The Medicaid Drug Rebate Program 2023-12-11-to-2023-12-17
U.S. Department of Health & Human Services
Finance and EconomicsNNDSS - TABLE 1NN. Viral Hemorrhagic Fevers, Junin Virus To Viral Hemorrhagic Fevers, Lujo Virus
U.S. Department of Health & Human Services
Demographics and Population StudiesProduct Data For Newly Reported Drugs In The Medicaid Drug Rebate Program 2023-01-16-to-2023-01-22
U.S. Department of Health & Human Services
Finance and EconomicsProduct Data For Newly Reported Drugs In The Medicaid Drug Rebate Program 2024-01-15-to-2024-01-21
U.S. Department of Health & Human Services
Finance and EconomicsProduct Data For Newly Reported Drugs In The Medicaid Drug Rebate Program 2023-08-07-to-2023-08-13
U.S. Department of Health & Human Services
Finance and EconomicsProduct Data For Newly Reported Drugs In The Medicaid Drug Rebate Program 20210823 To 20210829
U.S. Department of Health & Human Services
Finance and EconomicsProduct Data For Newly Reported Drugs In The Medicaid Drug Rebate Program 2023-03-27-to-2023-04-02
U.S. Department of Health & Human Services
Finance and EconomicsNNDSS - TABLE 1DD. Rubella To Rubella, Congenital Syndrome
U.S. Department of Health & Human Services
Demographics and Population StudiesProduct Data For Newly Reported Drugs In The Medicaid Drug Rebate Program 2023-11-13-to-2023-11-19
U.S. Department of Health & Human Services
Finance and EconomicsNNDSS - TABLE 1S. Invasive Pneumococcal Disease, All Ages, Confirmed To Invasive Pneumococcal Disease, All Ages, Probable
U.S. Department of Health & Human Services
HealthcareProduct Data For Newly Reported Drugs In The Medicaid Drug Rebate Program 2023-05-22-to-2023-05-28
U.S. Department of Health & Human Services
Finance and EconomicsProduct Data For Newly Reported Drugs In The Medicaid Drug Rebate Program 2022-03-14 To 2022-03-20
U.S. Department of Health & Human Services
Finance and EconomicsNNDSS - Table II. Invasive Pneumococcal To Legionellosis
U.S. Department of Health & Human Services
HealthcareNNDSS - TABLE 1X. Meningococcal Disease, Other Serogroups To Meningococcal Disease, Unknown Serogroup
U.S. Department of Health & Human Services
HealthcareProduct Data For Newly Reported Drugs In The Medicaid Drug Rebate Program 2023-12-04-to-2023-12-10
U.S. Department of Health & Human Services
Finance and EconomicsScorecard PILLAR VCORESET.1.1-test (coreset-local)
U.S. Department of Health & Human Services
Demographics and Population StudiesProduct Data For Newly Reported Drugs In The Medicaid Drug Rebate Program 2023-10-09-to-2023-10-15
U.S. Department of Health & Human Services
Finance and EconomicsProduct Data For Newly Reported Drugs In The Medicaid Drug Rebate Program 2023-02-06-to-2023-02-12
U.S. Department of Health & Human Services
Finance and EconomicsProduct Data For Newly Reported Drugs In The Medicaid Drug Rebate Program 20210809 To 20210815
U.S. Department of Health & Human Services
Finance and EconomicsProduct Data For Newly Reported Drugs In The Medicaid Drug Rebate Program 2023-06-05-to-2023-06-11
U.S. Department of Health & Human Services
Finance and EconomicsProduct Data For Newly Reported Drugs In The Medicaid Drug Rebate Program 2022-02-28 To 2022-03-06
U.S. Department of Health & Human Services
Finance and EconomicsProduct Data For Newly Reported Drugs In The Medicaid Drug Rebate Program 2023-09-25-to-2023-10-01
U.S. Department of Health & Human Services
Finance and EconomicsNNDSS - TABLE 1K. Ehrlichiosis And Anaplasmosis, Anaplasma Phagocytophilum Infection To Ehrlichia Chaffeensis Infection
U.S. Department of Health & Human Services
Demographics and Population StudiesProduct Data For Newly Reported Drugs In The Medicaid Drug Rebate Program 2023-01-23-to-2023-01-29
U.S. Department of Health & Human Services
Finance and EconomicsNNDSS - TABLE 1JJ. Tularemia To Vancomycin-intermediate Staphylococcus Aureus
U.S. Department of Health & Human Services
Demographics and Population StudiesProduct Data For Newly Reported Drugs In The Medicaid Drug Rebate Program 2023-02-27-to-2023-03-05
U.S. Department of Health & Human Services
Finance and EconomicsProduct Data For Newly Reported Drugs In The Medicaid Drug Rebate Program 2023-05-29-to-2023-06-04
U.S. Department of Health & Human Services
Finance and EconomicsProduct Data For Newly Reported Drugs In The Medicaid Drug Rebate Program 20210830 To 20210905
U.S. Department of Health & Human Services
Finance and Economics